CORT vs HAL · P/E 199, rev $675.0M vs P/E 9.3, $19.05B cap
Corcept Therapeutics Incorporated (CORT) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
HAL does not have a complete income-statement cache yet.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CORT and HAL stock pages for the full models.
Not investment advice.